Abstract Book
Vol. 98 No. s2 (2025): II Plastamination Conference - Naples, Italy, 15-17 October 2025
https://doi.org/10.4081/jbr.2025.14576

BIODEGRADABLE NANOPLASTIC: A TOOL FOR DRUG DELIVERY AND ENVIRONMENTAL CHALLENGE

Enza TORINO1,2,3, Anna MENALE1, Samuele FIORENZA1,2, Simona SILVESTRI1,3 | 1University of Naples Federico II - Department of Chemical, Materials Engineering and Industrial Production; 2Interdepartmental Research Center on Biomaterial (CRIB); 3Fondazione Istituto Italiano di Tecnologia – Center for Advanced Biomaterials for Healthcare

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Received: 16 October 2025
Published: 16 October 2025
144
Views

Authors

The emergence of nanoplastics as both a technological opportunity and an environmental concern has stimulated intense debate in biomedical engineering and materials science. On the one hand, nanoscale plastics have unique physicochemical properties such as large surface area, tunable surface chemistry, and high stability that make them attractive as carriers for targeted drug delivery. On the other hand, the uncontrolled release of non-biodegradable nanoplastics into ecosystems poses risks for human and environmental health, highlighting an urgent need for safer and more sustainable approaches. Biopolymers play a pivotal role in bridging this gap. Biodegradable polymers such as polylactic acid (PLA), polycaprolactone (PCL), and polysaccharide-based nanomaterials (e.g., chitosan, cellulose derivatives) can be engineered into nanoplastic-like carriers that retain the advantageous properties of conventional synthetic nanoparticles while avoiding long-term persistence in biological and environmental systems. Their tunable degradation rates, intrinsic biocompatibility, and ability to encapsulate both hydrophobic and hydrophilic drugs make them powerful tools for controlled release and precision medicine. However, it is also important for the fields of biopolymers to address the dual imperative of innovation and safety and the emerging paradigm of “safety-by-design” is being applied to polymeric and plastic-based systems. This approach integrates life cycle assessment, environmental fate modeling, and toxicological evaluation at the earliest stages of material design. The concept of safety-by-design (SbD) is emerging as a critical framework in the development of advanced materials and production technologies, particularly in the context of nanomaterials and plastic-derived systems. SbD advocates the proactive integration of safety considerations—human health, environmental fate, and ecotoxicological profiles at the earliest stages of material design and process development, rather than treating safety as a downstream regulatory checkpoint.

Downloads

Download data is not yet available.

How to Cite



BIODEGRADABLE NANOPLASTIC: A TOOL FOR DRUG DELIVERY AND ENVIRONMENTAL CHALLENGE: Enza TORINO1,2,3, Anna MENALE1, Samuele FIORENZA1,2, Simona SILVESTRI1,3 | 1University of Naples Federico II - Department of Chemical, Materials Engineering and Industrial Production; 2Interdepartmental Research Center on Biomaterial (CRIB); 3Fondazione Istituto Italiano di Tecnologia – Center for Advanced Biomaterials for Healthcare. (2025). Journal of Biological Research - Bollettino Della Società Italiana Di Biologia Sperimentale, 98(s2). https://doi.org/10.4081/jbr.2025.14576